OrthoPediatrics Corp. Crosses Milestone Treating 200,000 Children with Orthopedic Conditions
OrthoPediatrics Corp. (NASDAQ: KIDS) announced that over 200,000 children with orthopedic conditions have been treated using its products as of March 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announced that over 200,000 children with orthopedic conditions have been treated using its products as of March 2021. Founded in 2006, the company focuses exclusively on pediatric orthopedics, providing tailored surgical solutions that address the specific needs of children. OrthoPediatrics offers 35 surgical systems that cater to trauma, scoliosis, and sports medicine procedures. The company's mission remains dedicated to enhancing the quality and variety of treatments available for young patients globally.
Positive
- Over 200,000 children treated with OP products.
- Dedicated focus on pediatric orthopedics since 2006.
- 35 surgical systems marketed targeting trauma, scoliosis, and sports medicine.
Negative
- None.
Details
News Market Reaction – KIDS
The recorded move for KIDS in the trading session of this news was -4.25%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., March 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced that as of March 2021, it estimates over 200,000 children with orthopedic conditions have been treated with OP products.
“For over 14 years, OrthoPediatrics has been able to provide surgical solutions and treatments to help children. We are humbled to have now treated over 200,000 children,” commented David Bailey OrthoPediatrics President. “We remain dedicated to expanding the quality and range of our surgical solutions for children. We are excited to continue on our mission and help even more children around the world and to be at the forefront of addressing this unmet medical need.”
OrthoPediatrics was founded in 2006 to focus on the neglected field of orthopedic implants for children. By that time, implantable orthopedic devices in adults were becoming the norm, but too often, adult implants were modified in the operating room so they could be used in children. The Company’s vision was to address the problem of off-label use of adult implants by building a different kind of orthopedic company; a company focused exclusively on pediatric orthopedics and committed to the cause of improving the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
The Ruth Group
Christine Petraglia / James Salierno
Tel: 917-633-8980 / 973-255-8361
cpetraglia@theruthgroup.com / jsalierno@theruthgroup.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.